New San Diego Biotech Charts Stem-Cell Therapies for Heart Disease – Xconomy
New San Diego Biotech Charts Stem–Cell Therapies for Heart DiseaseXconomyCardioCell, a new San Diego biotech spun out of privately held Stemedica Cell Technologies, stepped into the light today, saying it is beginning a mid-stage clinical study in the United States to evaluate the use its proprietary stem cells to treat …CardioCell Launches AMI Therapy Trials … Continue reading
